BankPlus Trust Department’s Pfizer PFE Stock Holding History

BankPlus Trust Department’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Sell	12,552 -4,313	-26%	-$113K	0.07%	168
2026 Q1	$474K	Sell	16,865 -46,500	-73%	-$1.24M	0.13%	122
2025 Q4	$1.58M	Buy	63,365 +61	+0.1%	+$1.54K	0.41%	59
2025 Q3	$1.61M	Sell	63,304 -915	-1%	-$22.6K	0.43%	55
2025 Q2	$1.56M	Buy	64,219 +6,748	+12%	+$157K	0.46%	55
2025 Q1	$1.46M	Buy	57,471 +8,606	+18%	+$225K	0.49%	51
2024 Q4	$1.3M	Buy	+48,865	New	+$1.33M	0.43%	58

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BankPlus Trust Department's PFE Position: Q2 2026 in Review

BankPlus Trust Department reduced its Pfizer (PFE) stake by 26% in Q2 2026, selling an estimated $113K and leaving 12,552 shares worth $302K. The position accounts for 0.07% of the portfolio, ranked #168.

BankPlus Trust Department first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.61M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

BankPlus Trust Department held 12,552 shares of Pfizer worth $302K as of Q2 2026.
BankPlus Trust Department sold 4,313 Pfizer shares in Q2 2026, an estimated $113K.
Pfizer made up 0.07% of BankPlus Trust Department's portfolio in Q2 2026, its #168 holding.
BankPlus Trust Department first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
BankPlus Trust Department's Pfizer position peaked at $1.61M in Q3 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.